Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.
Launched by ERASMUS MEDICAL CENTER · Nov 29, 2022
Trial Information
Current as of February 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥70 years
- • 2. Tumor diagnosed as glioblastoma on MRI with distinct ring-like pattern of contrast enhancement with thick irregular walls and a core area reduced signal suggestive of tumor necrosis as assessed by the surgeon.
- • 3. Karnofsky Performance Score (KPS) ≥70
- • 4. Written Informed consent
- Exclusion Criteria:
- • 1. Tumors of the cerebellum, brain stem or midline
- • 2. Multifocal contrast enhancing lesions
- • 3. Substantial non-contrast enhancing tumor areas suggesting low grade gliomas with malignant transformation
- • 4. Medical reasons precluding MRI (e.g. pacemaker)
- • 5. Inability to give consent as assessed by neurosurgeon (e.g. language barrier)
- • 6. Severe aphasia prohibiting neurolinguistic testing and comprehension of informed consent
- • 7. Previous brain tumor surgery
- • 8. Previous low-grade glioma
- • 9. Second primary malignancy within the past 5 years with the exception of adequately treated in situ carcinoma of any organ or basal cell carcinoma of the skin.
Trial Officials
Arnaud J.P.E. Vincent, Prof. Dr.
Principal Investigator
Erasmus MC, department of neurosurgery
About Erasmus Medical Center
Erasmus Medical Center, located in Rotterdam, Netherlands, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution within the Erasmus University Rotterdam, the center integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a wide range of medical specialties. With a strong emphasis on multidisciplinary collaboration, Erasmus Medical Center aims to translate research findings into tangible clinical applications, enhancing treatment options and improving patient outcomes. The institution is dedicated to conducting ethical and rigorous clinical trials that contribute to the global body of medical knowledge and foster advancements in personalized medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rotterdam, , Netherlands
Maastricht, , Netherlands
Enschede, , Netherlands
Den Haag, , Netherlands
Rotterdam, Zuid Holland, Netherlands
Alkmaar, , Netherlands
Tilburg, , Netherlands
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials